These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 3601061

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time-course, distribution, and morphology of cell death.
    Stefanis L, Burke RE.
    Neuroscience; 1996 Oct; 74(4):997-1008. PubMed ID: 8895868
    [Abstract] [Full Text] [Related]

  • 3. Re-expression of glia-derived nexin/protease nexin 1 depends on mode of lesion-induction or terminal degeneration: observations after excitotoxin or 6-hydroxydopamine lesions of rat substantia nigra.
    Scotti AL, Monard D, Nitsch C.
    J Neurosci Res; 1994 Feb 01; 37(2):155-68. PubMed ID: 7908698
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transient and widespread astroglial activation in the brain after a striatal 6-OHDA-induced partial lesion of the nigrostriatal system.
    Gomide VC, Silveira GA, Chadi G.
    Int J Neurosci; 2005 Jan 01; 115(1):99-117. PubMed ID: 15768855
    [Abstract] [Full Text] [Related]

  • 6. Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex.
    Sastry S, Arendash GW.
    Neuroscience; 1995 Aug 01; 67(3):649-66. PubMed ID: 7545796
    [Abstract] [Full Text] [Related]

  • 7. Dizocilpine maleate, MK-801, but not 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline, NBQX, prevents transneuronal degeneration of nigral neurons after neurotoxic striatal-pallidal lesion.
    DeGiorgio LA, DeGiorgio N, Volpe BT.
    Neuroscience; 1999 Apr 01; 90(1):79-85. PubMed ID: 10188935
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons.
    Chadi G, Cao Y, Pettersson RF, Fuxe K.
    Neuroscience; 1994 Aug 01; 61(4):891-910. PubMed ID: 7838386
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sustained seizures cause circumscribed cerebral changes in glial fibrillary acidic protein, neurofilament and laminin immunofluorescence.
    Eriksdotter-Nilsson M, Björklund H, Dahl D, Olson L, Ingvar M.
    Exp Brain Res; 1987 Aug 01; 69(1):155-66. PubMed ID: 3125057
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G, Silva C, Maximino JR, Fuxe K, da Silva GO.
    Brain Res; 2008 Jan 23; 1190():23-38. PubMed ID: 18086466
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Short- and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes.
    Björklund H, Olson L, Dahl D, Schwarcz R.
    Brain Res; 1986 Apr 23; 371(2):267-77. PubMed ID: 2938667
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Astroglial cell alteration caused by neurotoxins: immunohistochemical observations with antibodies to glial fibrillary acidic protein, laminin, and tyrosine hydroxylase.
    Ogawa M, Araki M, Nagatsu I, Yoshida M.
    Exp Neurol; 1989 Nov 23; 106(2):187-96. PubMed ID: 2572449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.